Canaccord Genuity on AtriCure Inc. (ATRC): Bottom Line - Buy on Weakness
Tweet Send to a FriendGet Alerts ATRC Hot Sheet
Price: $9.30 +1.75%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Trade ATRC Now!
Canaccord Genuity maintains a 'Buy' on AtriCure Inc. (NASDAQ: ATRC) price target lowered to $12.00.
Analyst, Jason R. Mills, said, "Bottom line is we would be buyers of ATRC on weakness. That said, this is one of the most unique situations we’ve seen during our 13+-year sell-side tenure – a surprise CEO resignation simultaneous to record revenue, major progress on market development/regulatory initiatives (i.e., number of doctors trained, product /trial pipelines), and solid prospects for future growth. Quite honestly, we likely would’ve raised revenue estimates based on these results/trends, but David Drachman’s surprising resignation clearly creates significant near-term uncertainty."
For an analyst ratings summary and ratings history on AtriCure Inc. click here. For more ratings news on AtriCure Inc. click here.
Shares of AtriCure Inc. closed at $8.10 yesterday, with a 52 week range of $7.87-$12.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jason R. Mills, said, "Bottom line is we would be buyers of ATRC on weakness. That said, this is one of the most unique situations we’ve seen during our 13+-year sell-side tenure – a surprise CEO resignation simultaneous to record revenue, major progress on market development/regulatory initiatives (i.e., number of doctors trained, product /trial pipelines), and solid prospects for future growth. Quite honestly, we likely would’ve raised revenue estimates based on these results/trends, but David Drachman’s surprising resignation clearly creates significant near-term uncertainty."
For an analyst ratings summary and ratings history on AtriCure Inc. click here. For more ratings news on AtriCure Inc. click here.
Shares of AtriCure Inc. closed at $8.10 yesterday, with a 52 week range of $7.87-$12.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Lifts Numbers on Diana Shipping (DSX) Post Q1
- Topeka Capital Upgrades Pacific Sunwear of California (PSUN) to Buy
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
